课题基金 / 基金详情

Admin-Core-001

Admin-Core-001
管理核心-001
批准号:
10707661
负责人:
TZYY-CHOOU WU
金额:
$19.99万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-09-01 至 2024-08-31
关键词:

项目摘要

项目成果

TZYY-CHOOU WU的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract The Administration/Communication Core (Core A) is responsible for facilitating the coordination and oversight of all Program activities and for disseminating information within the SPORE and for external interactions. The Core is designed for low-cost, yet efficient administration and communication in order to focus funds on research activities. Core A includes a basic science director (Dr. T.-C. Wu) and a clinical research director (Dr. Warner Huh). Dr. Wu is responsible for coordinating basic scientific efforts and the coordination of individual projects. Dr. Huh oversees patient identification, enrollment, and patient monitoring in the context of the Core. The administrative component of the Core follows an organizational diagram for management activities. Monitoring of research will occur via: 1) Research Project Teams, 2) Committee of Research Project Leaders, 3) Core Investigators Committee, 4) Developmental Research Projects Program, 5) Career Enhancement Committee, and 6) the central SPORE Steering Committee. Furthermore, the Internal and External Advisory Boards provide formal evaluations and reports to the Steering Committee. This resource funds a Clinical Research Coordinator who interacts with the other cores as well as with personnel from each individual project to ensure that all patient information, specimens, and results are properly collected and recorded in the computerized database. Core A also funds patient advocate(s), who provide invaluable feedback on various SPORE activities from a unique perspective. Appropriate monitoring of patient safety, adverse events, and data management and confidentiality will be provided by the data safety monitoring boards. The communication component of the Core is directed at intra-SPORE, inter-SPORE, and National Cancer Institute research activities. The Core coordinates essential Program interactions including preparing applications and progress reports for the SPORE, all planning and evaluation activities, arranging and publicizing SPORE activities, coordinating advisory committee meetings, producing annual reports and performing analysis of budgetary matters.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
  • 批准号:
    10374864
  • 项目类别:
  • 资助金额:
    $57.12万
  • 财政年份:
    2019
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
  • 批准号:
    10618787
  • 项目类别:
  • 资助金额:
    $57.08万
  • 财政年份:
    2019
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
Ovarian cancer gene therapy using HPV pseudovirion
  • 批准号:
    9026581
  • 项目类别:
  • 资助金额:
    $33.62万
  • 财政年份:
    2014
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
(2/2) Howard University/Johns Hopkins Partnership in HPV-Related Cancer Research
  • 批准号:
    9330697
  • 项目类别:
  • 资助金额:
    $17.97万
  • 财政年份:
    2014
  • 负责人:
    TZYY-CHOOU WU
  • 依托单位:
国内基金
海外基金
胆固醇羟化酶CH25H非酶活依赖性促进乙型肝炎病毒蛋白Core及Pre-core降解的分子机制研究
  • 批准号:
    82371765
  • 项目类别:
    面上项目
  • 资助金额:
    50万元
  • 批准年份:
    2023
  • 负责人:
    谭广云
  • 依托单位:
锕系元素5f-in-core的GTH赝势和基组的开发
  • 批准号:
    22303037
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    鲁俊波
  • 依托单位:
基于合成致死策略搭建Core-matched前药共组装体克服肿瘤耐药的机制研究
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    孙丙军
  • 依托单位:
鼠伤寒沙门氏菌LPS core经由CD209/SphK1促进树突状细胞迁移加重炎症性肠病的机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    叶成林
  • 依托单位: